跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Combiflex Lipid Peri - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Combiflex Lipid Peri
Approved
STANDARD
Combiflex Lipid Peri
JW Life Science Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3a19348980e949e9
Company
JW Life Science Corporation
Type
Standard
Approval Details
Approval Id
3a19348980e949e9
Drug Approval Philippines Name
Combiflex Lipid Peri
Product Name
Combiflex Lipid Peri
Registration Number
DR-XY43760
Brand Name
Combiflex Lipid Peri
Generic Name
Lipid Emulsion + Amino Acids + Electrolytes + Glucose
Dosage Form
Emulsion for IV Infusion
Dosage Strength
[see reverse]
Manufacturer
JW Life Science Corporation
Importer
JW HEALTHCARE PHILIPPINES CORPORATION
Issuance Date
24 December 2021
Expiry Date
20 February 2027
Pharmacologic Category
Parenteral Nutrition
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3a19348980e949e9
Type
Standard
Back to Philippines FDA Approvals